Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2018 - 01 - 23
点击次数: 0
Positions: Vice President
Company: Hangzhou Tigermed Consulting Co., Ltd
个人简介:
•5 years’ working experience in RDPAC, devoted in the drug regulatory policy advocacy.•Before joining RDPAC, Maggie had 15 years’ working experience in the Department of Drug Registration and Clinical Trial in China subsidiaries of multinational pharmaceutical companies, including Schering AG, SmithKline Beecham and Schering-Plough.
发布时间: 2018 - 01 - 23
点击次数: 0
Positions: PhD
Company: dMed
个人简介:
•       20+ years in biostatistics, clinical development and registration strategy in BioPharma and CRO/consultant companies, as well as new drug R&D administration in FDA•       Served as R&D lead participated in British pubic IPO roadshow for a Shenzhen based Pharma and led a hardware development program of a Cardiac Diagnostic Medical Intelligence for a Beijing based medical device company•       Currently still serves as a Adjunct  Professor in Biostatistics of Yale University and contributed to setting up the Joint Biostatistics Center of Shanghai Jiaotong and Yale University, which is focused on bioinformatics, precision medicine and big data in healthcare etc•       A recipient of the top ten United States-Chinese medical scientists by United States Medical Association and  published many academic peer review papers•       BS in Mathematics from Peking University and PhD in Biostatistics from Yale University; EMBA from Columbia University
发布时间: 2018 - 01 - 23
点击次数: 0
Positions: Chairman of Scientific Advisory Board
Company: MITRO Biotech. Co., Ltd.
个人简介:
His research interests span the disciplines of multimodality molecular imaging research and radiopharmaceutical drug discovery. His current research projects include: (1) preclinical and clinical imaging research on cancer, CNS, and autoimmune diseases with multimodality imaging techniques, such as microPET/SPECT/CT, MRI, ultrasound, and optical devices. (2) Radiopharmaceutical drug development on bioconjugation and radiolabeling of proteins, peptides, oligonucleotides, and small organic molecules for theranostic imaging and targeted radiation therapy.
发布时间: 2018 - 01 - 23
点击次数: 0
Positions: President & CEO
Company: Shanghai LIDE Biotech
个人简介:
Danyi Wen, President & CEO of Shanghai LIDE Co. Ltd.  Register on 2011, Shanghai LIDE focus on providing services and biomarker product R&D to support “Personalized Precision Medicine”. There are two subsidiary companies under Shanghai LIDE:  Xian LIDE Biotech and Shanghai LIWEN Clinical Testing Lab.  Shanghai LIDE was public listed on New Third Board (Over the counter trading) on Aug 2016.  B.S from the Forth Military Medical University; M.S from Peking Union Medical University/Chinese Academy of Medical Sciences;MBA from Suffolk University; Post-Doc and Instructor of Medicine at Harvard Medical School (Brigham & Women’s Hospital); 12 years industry experience at Millennium Pharmaceutical, Biogen-Idec.  Returning back to China on 2007 as VP of Biology at Shanghai ChemPartner.  Founded Shanghai LIDE Biotech at the end of 2011. Adjourn professor of Beijing Xiehe Hospital and School of Pharmacy of Fudan University; Editor of “Progress in Pharmaceutical Sciences”; Associate of Chinese anti-cancer Association (society of Liver, bile, Pancreatic); Vice Group Leader of CMBA Tissue Bank Society, PDX Group.  2013 Danyi was elected as “Shanghai Thousand Talent Expert”